| Bannel Associates Llc | |
|
405 W Oak St Kissimmee FL 34741-4931 | |
| (407) 955-6719 | |
| Not Available |
| Full Name | Bannel Associates Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 405 W Oak St, Kissimmee, Florida |
| Authorized Official Name and Position | Nelson Gonzalez Rodriguez (PRESIDENT) |
| Authorized Official Contact | 4073502120 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bannel Associates Llc 405 W Oak St Kissimmee FL 34741-4931 Ph: (407) 955-6719 | Bannel Associates Llc 405 W Oak St Kissimmee FL 34741-4931 Ph: (407) 955-6719 |
| NPI Number | 1215623665 |
|---|---|
| Provider Enumeration Date | 04/17/2023 |
| Last Update Date | 04/17/2023 |
| Certification Date | 04/17/2023 |
| Medicare PECOS PAC ID | 6901240936 |
|---|---|
| Medicare Enrollment ID | O20240219001209 |
News Archive
StemCells, Inc. announced today that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,361,505 with broad claims covering human neural stem cells derived from any tissue source, including embryonic, fetal, juvenile, or adult tissue. The ‘505 patent is exclusively licensed to StemCells.
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases. While the mechanism for this association is unclear, the study identifies a potentially modifiable risk factor and highlights a potential way to decrease the incidence of the disease.
Dental fluorosis, a result of exposure to excessive fluoride during enamel formation, is one of the most common developmental enamel defects, according to background information in the article.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215623665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Orly Pena Sanchez |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1447212295 PECOS PAC ID: 7315962859 Enrollment ID: I20081018000123 |
News Archive
StemCells, Inc. announced today that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,361,505 with broad claims covering human neural stem cells derived from any tissue source, including embryonic, fetal, juvenile, or adult tissue. The ‘505 patent is exclusively licensed to StemCells.
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases. While the mechanism for this association is unclear, the study identifies a potentially modifiable risk factor and highlights a potential way to decrease the incidence of the disease.
Dental fluorosis, a result of exposure to excessive fluoride during enamel formation, is one of the most common developmental enamel defects, according to background information in the article.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
› Verified 5 days ago
News Archive
StemCells, Inc. announced today that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,361,505 with broad claims covering human neural stem cells derived from any tissue source, including embryonic, fetal, juvenile, or adult tissue. The ‘505 patent is exclusively licensed to StemCells.
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases. While the mechanism for this association is unclear, the study identifies a potentially modifiable risk factor and highlights a potential way to decrease the incidence of the disease.
Dental fluorosis, a result of exposure to excessive fluoride during enamel formation, is one of the most common developmental enamel defects, according to background information in the article.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
› Verified 5 days ago
Intervention Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 804 N Hoagland Blvd., Kissimmee, FL 34741 Phone: 407-931-2911 | |
Beltran Behavioral Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3214 Hillsdale Lane, Kissimmee, FL 34741 Phone: 407-518-9161 Fax: 407-518-9942 | |
Life Work Soul Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3206 Hillsdale Ln, Kissimmee, FL 34741 Phone: 407-530-5911 Fax: 888-216-6045 | |
I Beliv You Matter 'llc' Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 716 Hughey St, Kissimmee, FL 34741 Phone: 407-283-1308 | |
Breakthrough Behavior Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3831 W Vine St Ste 60, Kissimmee, FL 34741 Phone: 407-559-4854 Fax: 407-965-4480 | |
Cornerstone Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 N Thacker Ave Ste D31, Kissimmee, FL 34741 Phone: 321-732-2315 Fax: 321-222-6228 | |
Tree House Therapy Services Corp. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 W Darlington Ave, Kissimmee, FL 34741 Phone: 407-350-3630 |